Document is current
Any future updates will be listed below
-
Authors
Stenehjem, David D. https://orcid.org/0000-0002-1831-285X
Telford, Claire
Unni, Sudhir K.
Bauer, Hillevi
Sainski, Amy
Deka, Rishi
Schauerhamer, Marisa B.
Ye, Xiangyang
Tak, Casey R.
Ma, Junjie
Dalvi, Tapashi B.
Gutierrez, Lia
Kaye, James A.
Tyczynski, Jerzy E.
Brixner, Diana I.
Biskupiak, Joseph E.
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 19 August 2020
Accepted: 25 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Stenehjem, Brixner, Biskupiak, Kaye and Gutierrez received funding through their institutions from AstraZeneca to complete the research described in the manuscript. Telford, Tyczynski, and Dalvi are or were employees of AstraZeneca at the time the research was conducted and hold stock in AstraZeneca. Unni, Bauer, Sainski, Deka, Schauerhamer, Ye, Tak, and Ma declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of the University of Utah and the Huntsman Cancer Institute’s Protocol Review and Monitoring Committee.
: Informed consent was waived through an exemption from the University of Utah Institutional Review Board.
